Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SPECIALLÆGESELSKABET KIRURGISK KLINIK, ÅRHUS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.7% 0.7%   Bankruptcy risk   1.7% 2.4% 3.2% 24.6% 18.8% 21.9% 9.3% 9.3%   Credit score (0-100)   75 66 57 4 7 3 26 25   Credit rating   A BBB BBB B B B BB BB   Credit limit (kDKK)   5.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,936 4,914 14,299 -123 -18.5 -3.6 0.0 0.0   EBITDA   2,328 2,495 11,499 -250 -18.5 -3.6 0.0 0.0   EBIT   2,170 2,380 11,403 -250 -18.5 -3.6 0.0 0.0   Pre-tax profit (PTP)   2,215.2 2,533.5 11,633.4 161.2 137.1 -3.7 0.0 0.0   Net earnings   1,727.6 1,976.4 9,073.6 125.9 106.9 -2.9 0.0 0.0   Pre-tax profit without non-rec. items   2,215 2,533 11,633 96.5 137 -3.7 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Tangible assets total   189 73.9 595 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   3,634 5,610 13,684 3,810 3,917 3,914 3,789 3,789   Interest-bearing liabilities   364 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,805 6,617 16,741 3,996 3,957 3,924 3,789 3,789   Net Debt   -533 -1,048 -509 -9.2 0.0 -1.8 -3,789 -3,789     See the entire balance sheet 1000.0 Volume  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,936 4,914 14,299 -123 -18.5 -3.6 0.0 0.0   Gross profit growth   0.0% -0.4% 191.0% 0.0% 84.9% 80.3% 0.0% 0.0%   Employees   5 4 5 5 0 0 0 0   Employee growth %   0.0% -20.0% 25.0% 0.0% -100.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   4,805 6,617 16,741 3,996 3,957 3,924 3,789 3,789   Balance sheet change%   0.0% 37.7% 153.0% -76.1% -1.0% -0.8% -3.4% 0.0%   Added value   2,327.9 2,495.2 11,499.3 -250.3 -18.5 -3.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   31 -230 425 -595 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 -1.0 -2.0 -3.0 0.0 0.0   1000.0 Profitability  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   44.0% 48.4% 79.7% 203.6% 100.0% 100.0% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   46.3% 44.4% 99.7% 0.9% 3.4% -0.1% 0.0% 0.0%   ROI %   55.7% 52.7% 119.8% 1.1% 3.5% -0.1% 0.0% 0.0%   ROE %   47.5% 42.8% 94.1% 1.4% 2.8% -0.1% 0.0% 0.0%   1000.0 Solidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Equity ratio %   75.6% 84.8% 81.7% 95.3% 99.0% 99.7% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -22.9% -42.0% -4.4% 3.7% -0.2% 48.8% 0.0% 0.0%   Gearing %   10.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   6.2% 0.0% 0.0% 0.0% 52.2% 143.5% 0.0% 0.0%   1000.0 Liquidity  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Quick Ratio   3.9 6.5 5.5 21.4 98.4 391.3 0.0 0.0   Current Ratio   3.9 6.5 5.5 21.4 98.4 391.3 0.0 0.0   Cash and cash equivalent   896.9 1,048.4 509.3 9.2 0.0 1.8 0.0 0.0   1000.0 Capital use efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   3,445.0 5,536.6 13,220.1 3,810.0 3,916.9 3,914.0 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2016 2016/12 2017 2017/12 2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022e N/A 2023e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   466 624 2,300 -50 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   466 624 2,300 -50 0 0 0 0   EBIT / employee   434 595 2,281 -50 0 0 0 0   Net earnings / employee   346 494 1,815 25 0 0 0 0